Economics ❯Healthcare Costs

Drug Pricing

Federal Spending Medicare Spending Subsidies Prescription Drugs Economic Impact of Addiction Mounjaro Insurance Coverage Market Dynamics Insurance Premiums Generic Drugs US Healthcare System Opioid Medications Market Competition

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

The deal, which could reach $2 billion with milestones, positions GSK to target unmet needs in liver disease with a planned 2029 launch.

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Trump Administration Rejects Biden-Era Plan to Expand Medicare Coverage for Weight-Loss Drugs

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Trump Implements Tariffs Targeting Fentanyl Trafficking from China, Mexico, and Canada